Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial Hospital
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
PembRolIzuMab and Stereotactic Body Radiotherapy In Metastatic Non-small-cell lunG Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Mychoice: Testing an Interactive mHealth Tool
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Helping Empower Liver and Kidney Patients
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
EBR/GZR for HCV-1b Patients Receiving Hemodialysis
- Status
- COMPLETED
- Phase
- PHASE4
Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Hepatitis C (HCV) Cure and Kidney Health
- Status
- UNKNOWN
- Phase
- N/A
Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Self-efficacy, Beliefs and Adherence- Pilot and Feasibility Trial of a Pharmacist-led Intervention
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Pembrolizumab Following TACE in Primary Liver Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2